Exact Mass: 370.1537

Exact Mass Matches: 370.1537

Found 29 metabolites which its exact mass value is equals to given mass value 370.1537, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

thioridazine

Thioridazine (oxide)

C21H26N2S2 (370.1537)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Thioridazine

10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine

C21H26N2S2 (370.1537)


A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618) N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

Apabetalone

2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-1,4-dihydroquinazolin-4-one

C20H22N2O5 (370.1529)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Methyl (3R,3'S,8'S,10'R)-2-oxospiro[1H-indole-3,12'-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7'-carboxylate

Methyl (3R,3s,8s,10r)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylic acid

C20H22N2O5 (370.1529)


   

MEF-Glu

MEF-Glu

C20H22N2O5 (370.1529)


CONFIDENCE Tentative identification only (Level 3); ALGAE_TP_ID 3201

   

2-Deoxystreptamine,9CI-N,N-Dibenzoyl

2-Deoxystreptamine,9CI-N,N-Dibenzoyl

C20H22N2O5 (370.1529)


   

gelsemolenine B

gelsemolenine B

C20H22N2O5 (370.1529)


   

14-deoxy-GS-1|gelegamine E

14-deoxy-GS-1|gelegamine E

C20H22N2O5 (370.1529)


   

N-[(diphenylmethoxy)acetyl]-Glutamine

N-[(diphenylmethoxy)acetyl]-Glutamine

C20H22N2O5 (370.1529)


   

Z-Ala-Phe-OH

Z-Ala-Phe-OH

C20H22N2O5 (370.1529)


   

Z-Phe-Ala-OH

Z-Phe-Ala-OH

C20H22N2O5 (370.1529)


   

2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone

2,6-bis(4-azidobenzylidene)-4-methylcyclohexanone

C21H18N6O (370.1542)


   

Ac-D-Phe-Tyr-OH

Ac-D-Phe-Tyr-OH

C20H22N2O5 (370.1529)


   

(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide

(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide

C20H22N2O5 (370.1529)


   

3-[(4-Hydroxybenzoyl)amino]azepan-4-YL 4-hydroxybenzoate

3-[(4-Hydroxybenzoyl)amino]azepan-4-YL 4-hydroxybenzoate

C20H22N2O5 (370.1529)


   

RVX-208

Apabetalone

C20H22N2O5 (370.1529)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Methyl (3R,3S,8S,10R)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylate

Methyl (3R,3S,8S,10R)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylate

C20H22N2O5 (370.1529)


   

5-[4-(2-Furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid

5-[4-(2-Furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid

C20H22N2O5 (370.1529)


   

5-(1,3-Benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester

5-(1,3-Benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester

C20H22N2O5 (370.1529)


   

2-Amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile

2-Amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile

C20H22N2O5 (370.1529)


   

2-Amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile

2-Amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile

C20H22N2O5 (370.1529)


   

2-[[[2-[[(4-Methoxyphenyl)-oxomethyl]amino]phenyl]-oxomethyl]amino]-3-methylbutanoic acid

2-[[[2-[[(4-Methoxyphenyl)-oxomethyl]amino]phenyl]-oxomethyl]amino]-3-methylbutanoic acid

C20H22N2O5 (370.1529)


   

6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one

6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one

C20H22N2O5 (370.1529)


   

1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione

1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione

C20H22N2O5 (370.1529)


   

(1s,11r,12r,17r)-12-acetyl-6-hydroxy-10-(methoxycarbonyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-14-olate

(1s,11r,12r,17r)-12-acetyl-6-hydroxy-10-(methoxycarbonyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-14-olate

C20H22N2O5 (370.1529)


   

(1'r,3s,4's,8'r,9's)-1,6-dimethoxy-2-oxo-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-6'-ene-7'-carbaldehyde

(1'r,3s,4's,8'r,9's)-1,6-dimethoxy-2-oxo-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-6'-ene-7'-carbaldehyde

C20H22N2O5 (370.1529)


   

(1'r,3s,4's,7'r,8's)-6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one

(1'r,3s,4's,7'r,8's)-6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one

C20H22N2O5 (370.1529)


   

n-[(1r,2s,4s,5s)-1'-methoxy-2'-oxo-9-propanoyl-7-oxaspiro[bicyclo[3.2.2]nonane-2,3'-indol]-8-en-4-yl]carboximidic acid

n-[(1r,2s,4s,5s)-1'-methoxy-2'-oxo-9-propanoyl-7-oxaspiro[bicyclo[3.2.2]nonane-2,3'-indol]-8-en-4-yl]carboximidic acid

C20H22N2O5 (370.1529)


   

(2r,6r)-1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione

(2r,6r)-1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione

C20H22N2O5 (370.1529)